We have now identified some in vivo trials for soft tissue sarcomas, most of which utilize viral transduction into cells prior to xenografting into mice, while few trials have utilized systemic administration of oligonucleotide.
Although some agents have been proven effective for combating the pathogenesis of ALS in mice, the clinical trials have shown negative results, and no therapeutic agents of ALS have yet been developed.
Every fifth trial was a probe trial (on which no puff was delivered) however as these amounted to only 10 probe trials per mouse, data from these trials have not been used for any specific analysis.
The mechanism leading to cell specificity of mTORC2 inhibition by rapamycin is not understood and is especially important because many of the negative metabolic side effects of rapamycin, reported in mouse studies and human clinical trials, have been attributed recently to mTORC2 inhibition.
84 Antigen therapy of T1D by administration of insulin, GAD, peptides, or other islet antigens with various adjuvant formulations or delivery methods has proven effective in mice, but thus far clinical trials have shown only limited or no benefits.
In addition to our experiments on hOR17-4, we have constructed optimized synthetic genes for several mouse olfactory receptors and initial expression trials have proven successful.
Comparatively, very few experimental trials have examined influenza viruses of the H9 subtype in mice.
Drp1cKO mice performed normally in cued platform trials, had normal swim speeds, and showed no abnormalities in open-field behavior, indicating that their water maze deficits were not caused by deficits in vision or motor function.
On a total of 90 trials per group, only two trials had to be excluded in Tc1 mice, whereas 14 trials were eliminated in WT mice.
"We had Mickey Mouse trials in the past and we saw the results.
